Changes of serum adenosine deaminase level in new cases of pulmonary tuberculosis before and after intensive phase treatment
- PMID: 32108596
- PMCID: PMC7065539
- DOI: 10.4103/lungindia.lungindia_395_19
Changes of serum adenosine deaminase level in new cases of pulmonary tuberculosis before and after intensive phase treatment
Abstract
Background and objectives: Tuberculosis (TB) continues to be a public health crisis with an estimated 10 million people developing TB disease in 2017. Adenosine deaminase (ADA) level in serum and pleural fluid as a biomarker may be used to diagnose pulmonary TB (PTB), but it is not always easy to obtain those samples at the end of treatment. This study was conducted to analyze the changes of serum ADA level in the new case of PTB patients with acid-fast bacilli (AFB) smear-positive sputum and sputum conversion status as treatment monitoring in PTB patients.
Materials and methods: This was a prospective observational analytic study conducted in Dr. Soetomo General Hospital, Surabaya, from January 2018 to May 2018. Participants were all new cases of PTB patients with AFB smear-positive sputum, and a positive rapid molecular test for Mycobacterium tuberculosis. Blood serums were taken at the same time on the 1st day of TB treatment and also taken at the end of intensive phase treatment to analyze the changes of serum ADA level.
Results: There were 26 TB patients and 26 healthy control people. Serum ADA level at the beginning of TB treatment was higher than the level at the end of intensive phase treatment. There was a significant difference between serum ADA level before and after the intensive phase of TB treatment (P < 0.001).
Conclusions: The examination of serum ADA levels can be used to evaluate the PTB treatment response.
Keywords: Pulmonary tuberculosis; serum adenosine deaminase; sputum conversion.
Conflict of interest statement
None
Similar articles
-
Role of serum adenosine deaminase in pulmonary tuberculosis.Indian J Tuberc. 2018 Jan;65(1):30-34. doi: 10.1016/j.ijtb.2017.08.001. Epub 2017 Aug 8. Indian J Tuberc. 2018. PMID: 29332644
-
Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.Indian J Tuberc. 2019 Jan;66(1):134-138. doi: 10.1016/j.ijtb.2018.07.007. Epub 2018 Oct 12. Indian J Tuberc. 2019. PMID: 30797271
-
Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis.Int J Tuberc Lung Dis. 2009 Jun;13(6):744-8. Int J Tuberc Lung Dis. 2009. PMID: 19460251
-
Role of Anaemia and Magnesium Levels at the Initiation of Tuberculosis Therapy with Sputum Conversion among Pulmonary Tuberculosis Patients.J Clin Diagn Res. 2017 Jun;11(6):BC01-BC04. doi: 10.7860/JCDR/2017/23734.9975. Epub 2017 Jun 1. J Clin Diagn Res. 2017. PMID: 28764146 Free PMC article.
-
Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.BMC Infect Dis. 2016 Aug 2;16:365. doi: 10.1186/s12879-016-1712-y. BMC Infect Dis. 2016. PMID: 27484399 Free PMC article.
Cited by
-
Plasma ferritin, C-reactive protein, and adenosine deaminase levels in tuberculous lymphadenitis and pleuritis and their role in monitoring treatment response.BMC Infect Dis. 2024 Dec 2;24(1):1375. doi: 10.1186/s12879-024-10228-z. BMC Infect Dis. 2024. PMID: 39623309 Free PMC article.
-
Factors associated with negative pleural adenosine deaminase results in the diagnosis of childhood pleural tuberculosis.BMC Infect Dis. 2021 May 25;21(1):473. doi: 10.1186/s12879-021-06209-1. BMC Infect Dis. 2021. PMID: 34034670 Free PMC article.
-
ADA as main biochemical marker in patients with tuberculous effusion.J Med Biochem. 2023 Oct 27;42(4):722-726. doi: 10.5937/jomb0-44018. J Med Biochem. 2023. PMID: 38084235 Free PMC article.
-
Correlation of serum Adenosine Deaminase levels with microbiological parameters in Pulmonary Tuberculosis.Indian J Clin Biochem. 2024 Jul;39(3):380-386. doi: 10.1007/s12291-023-01116-5. Epub 2023 Feb 1. Indian J Clin Biochem. 2024. PMID: 39005875 Free PMC article.
-
Adenosine Deaminase and Systemic Immune Inflammatory Index-A Biomarker Duet Signature of Pulmonary Tuberculosis Severity.Medicina (Kaunas). 2025 Jun 17;61(6):1096. doi: 10.3390/medicina61061096. Medicina (Kaunas). 2025. PMID: 40572784 Free PMC article.
References
-
- World Health Organization. Global Tuberculosis Report 2015. Geneva: World Health Organization; 2016. pp. 1–34.
-
- Albert H, Heydenrych A, Brookes R, Mole RJ, Harley B, Subotsky E, et al. Performance of a rapid phage-based test, FASTPlaqueTB, to diagnose pulmonary tuberculosis from sputum specimens in South Africa. Int J Tuberc Lung Dis. 2002;6:529–37. - PubMed
-
- Levinson W. Review of Medical Microbiology and Immunology. United States: The McGraw-Hill Companies Inc; 2008. p. 164.
-
- Barua R, Hossain M. Adenosin deaminase in diagnosis of tuberculosis: A review. Anwer Khan Mod Med Coll J. 2014;5:43–8.
-
- Rutta E, Kipingili R, Lukonge H, Assefa S, Mitsilale E, Rwechungura S. Treatment outcome among Rwandan and Burundian refugees with sputum smear-positive tuberculosis in Ngara, Tanzania. Int J Tuberc Lung Dis. 2001;5:628–32. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials